Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity

Cell

Volumn 92, Issue 3, 1998, Pages 391-400

  Brooks, Peter C ^b   Silletti, Steve ^b   Von Schalscha, Tami L ^b   Friedlander, Martin ^a   Cheresh, David A ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; METALLOPROTEINASE;

ANGIOGENESIS; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CHORIOALLANTOIS; ENZYME ACTIVITY; GENE DISRUPTION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0010712792     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80931-9     Document Type: Article

References (41)

1. Aimes, R.T., French, D.L., and Quigley, J.P. (1994). Cloning of a 72 kDa matrix metalloproteinase (gelatinase) from chicken embryo fibroblasts using gene family PCR: expression of the gelatinase increases upon malignant transformation. Biochem. J. 200, 729-736.
2. Anand-Apte, B., Pepper, M.S., Voest, E., Montesano, R., Olsen, B., Murphy, G., Apte, S.S., and Zetter, B. (1997). Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest. Opthalmol. 38, 817-823.
3. Auerbach, W., and Auerbach, R. (1994). Angiogenesis inhibition: a review. Pharmacol. Ther. 63, 265-311.
4. Blood, C.H., and Zetter, B.R. (1990). Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochem. Biophys. Acta 1032, 89-118.
5. Brooks, P.C., Clark, R.A.F., and Cheresh, D.A. (1994a). Requirement of vascular integrin αvβ3 for angiogenesis. Science 264, 569-571.
6. Brooks, P.C., Montgomery, A.M.P., Rosenfeld, M., Reisfeld, R.A., Hu, T., Klier, G., and Cheresh, D.A. (1994b). Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164.
7. Brooks, P.C., Stromblad, S., Klemke, R., Visscher, D., Sarkar, F.H., and Cheresh, D.A. (1995). Antiintegrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. 96, 1815-1822.
8. Brooks, P.C., Stromblad, S., Sanders, L.C., von Schalscha, T.L., Aimes, R.T., Stetler-Stevenson, W.G., Quigley, J.P., and Cheresh, D.A. (1996). Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 85, 683-693.
9. Cao, J., Rehemtulla, A., Bahou, W., and Zucker, S. (1996). Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain. J. Biol. Chem. 271, 30174-30180.
10. Cheresh, D.A., and Spiro, R.C. (1987). Biosynthesis and functional properties of Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen and von Willebrand factor. Proc. Natl. Acad. Sci. USA 84, 6471-6475.
11. Cheresh, D.A., Berliner, S.A., Vicente, V., and Ruggeri, Z. (1989). Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 58, 945-953.
12. D'Amore, P.A., and Thompson, R.W. (1987). Mechanisms of angiogenesis. Annu. Rev. Physiol. 49, 453-464.
13. DeClerck, Y.A., and Laug, W.E. (1996). Cooperation between matrix metalloproteinase and the plasminogen activator-plasmin system in tumor progression. Enz. Prot. 49, 72-84.
14. Filardo, E.J., Brooks, P.C., Deming, S.L., Damsky, C., and Cheresh, D.A. (1995). Requirement of the NPXY motif in the integrin β3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo. J. Cell Biol. 130, 441-450.
15. Foda, H.D., George, S., Conner, C., Drews, M., Tompkins, D.C., and Zucker, S. (1996). Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane type matrix metalloproteinase. Lab. Invest. 74, 538-545.
16. Folkman, J. (1995). Clinical applications of research on angiogenesis. N. Engl. J. Med. 333, 1757-1763.
17. Folkman, J., and D'Amore, P.A. (1996). Blood vessel formation: what is its molecular basis? Cell 87, 1153-1155.
18. Fridman, R., Fuerst, T.R., Bird, R.E., Hoyhtya, M., Oelkuct, M., Kraus, S., Komarek, D., Liotta, L.A., Berman, M.L., and Stetler-Stevenson, W.G. (1992). Domain structure of human 72-kDa gelatinase/type IV collagenase. J. Biol. Chem. 267, 15398-15405.
19. Friedlander, M., Brooks, P.C., Shaffer, R.W., Kincade, C.M., Varner, J.A., and Cheresh, D.A. (1995). Definition of two angiogenic pathways by distinct αv integrins. Science 270, 1500-1502.
20. Friedlander, M., Theesfeld, C.L., Sugita, M., Fruttiger, M., Thomas, M.A., Chang, S., and Cheresh, D.A. (1996). Involvement of integrins αvβ3 and αvβ5 in ocular neovascular diseases. Proc. Natl. Acad. Sci. USA 93, 9764-9769.
21. Galardy, R.E., Grobelny, D., Foellmer, H.G., and Fernandez, L.A. (1994). Inhibition of angiogenesis by matrix metalloproteinase inhibitor N-[2r-2(hydryoxamidocarbonymethy)-4-methylpentanoyl)]-L-trypt ophan methylamide. Cancer Res. 54, 4715-4718.
22. Grant, D.S., Tashiro, K., Segui-Real, B., Yamada, Y., Martin, G.R., and Kleinman, H.K. (1989). Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 58, 933-943.
23. Hanahan, D., and Folkman, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
24. Howard, E.W., Bullen, E.C., and Banda, M.J. (1991). Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinase-2. J. Biol. Chem. 266, 13064-13069.
25. Ingber, D.E., and Folkman, J. (1989). Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J. Cell Biol. 109, 317-330.
26. Mignatti, P., and Rifkin, D.B. (1993). Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 72, 161-185.
27. Montgomery, A.M.P., Reisfeld, R.A., and Cheresh, D.A. (1994). Integrin αvβ3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc. Natl. Acad. Sci. USA 91, 8856-8860.
28. Moses, M.A., Sudhalter, J., and Langer, R. (1990). Identification of an inhibitor of neovascularization from cartilage. Science 248, 1408-1410.
29. O'Reilly, M.S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W.S., Flynn, E., Birkhead, J.R., Olsen, B.R., and Folkman, J. (1997). Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285.
30. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. (1994). A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370, 61-65.
31. Senger, D. (1996). Molecular framework for angiogenesis. Am. J. Pathol. 149, 1-7.
32. Smith, J.W., Vestal, D.J., Irwin, S.V., Burke, T.A., and Cheresh, D.A. (1990). Purification and functional characterization of integrin αvβ5. J. Biol. Chem. 265, 11008-11013.
33. Stetler-Stevenson, W.G. (1996). Dynamics of matrix turnover during pathological remodeling of the extracellular matrix. Am. J. Pathol. 148, 1345-1350.
34. Stetler-Stevenson, W.G., Liotta, L., and Kleiner, D.E. (1993). Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7, 1434-1441.
35. Stone, J., Itin, A., Alon, T., Pe'er, J., Bnessin, H., Chan-Ling, T., and Keshet, E. (1995). Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor expression. J. Neurosci. 15, 4738-4747.
36. Strongin, A.Y., Marmer, B.L., Grant, G.A., and Goldberg, G.I. (1993). Plasma membrane-dependent activation of the 72-kDatype IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem. 268, 14033-14039.
37. Strongin, A.Y., Collier, I., Bannikov, G., Marmer, B.L., Grant, G.A., and Goldberg, G.I. (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase. J. Biol. Chem. 270, 5331-5338.
38. Tolsma, S.S., Volpert, O.V., Good, D.J., Frazier, W.A., Polverini, P.J., and Bouck, N. (1993). Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol. 122, 497-511.
39. Volpert, O.V., Tolsma, S.S., Pellerin, S., Feige, J.-J., Chen, H., Mosher, D.F., and Bouck, N. (1995). Inhibition of angiogenesis by thrombospondin-2. Biochem. Biophys. Res. Commun. 217, 326-332.
40. Ward, R.V., Atkinson, S.J., Slocombe, P.M., Docherty, A.J.P., Reynolds, J.J., and Murphy, G. (1991). Tissue inhibitor of metalloproteinase-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochem. Biophys. Acta. 1079, 242-246.
41. Zucker, S., Conner, C., DiMassmo, B.I., Endes, H., Drews, M., Seiki, M., and Bahous, W.F. (1995). Thrombin induces the activation of progelatinase A in vascular endothelial cells. J. Biol. Chem. 270, 23730-23738.